A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

about

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

Item

http://www.wikidata.org/entity/Q48023237

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

@en

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

@nl

type

Item

label

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

@en

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

@nl

prefLabel

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

@en

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

@nl

P1476

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

@en

P2093

Alan Menter

http://www.w3.org/2001/XMLSchema#string

Dario Kivelevitch

http://www.w3.org/2001/XMLSchema#string

Omid Roostaeyan

http://www.w3.org/2001/XMLSchema#string

P2860

Profile of certolizumab and its potential in the treatment of psoriatic arthritis

IL-17C regulates the innate immune function of epithelial cells in an autocrine manner

Structure and signalling in the IL-17 receptor family

Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells

Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice

Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma

Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance

P304

963-978

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2017-0077

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28879789

http://www.w3.org/2001/XMLSchema#string